Views
7 months ago

2017 HCHB_digital

SUDAFED PE SINUS DAY +

SUDAFED PE SINUS DAY + NIGHT RELIEF JOHNSON & JOHNSON (NEW ZEALAND) LTD Presentation: Tablets, 24s, 48s. Active Ingredients: Day Tablet: Phenylephrine hydrochloride 5mg, paracetamol 500mg. Night Tablet: Phenylephrine hydrochloride 5mg, paracetamol 500mg chlorpheniramine maleate 2mg. Approved Indications: Relief of sinus and nasal congestion and associated pain. Contraindications: Concurrent use of anti-histamines, paracetamol or antidepressants, or within 2 weeks of stopping an MAOI. Precautions: Ask your doctor before taking if you have high blood pressure, heart problems, are pregnant, or take other medicines for cough or cold. Adverse Effects: Phenylephrine may cause sleeplessness. Chlorpheniramine may cause drowsiness. Directions: Adults and children over 12 years: 2 tablets every 4-6 hours. Maximum 6 day & 2 night tablets in 24 hours. Price Band: $10 - $20 (Price varies with pack size) Subsidy Conditions: Not subsidised Medicine Classification: Pharmacy Only Medicine »» Sleep Problems DOZILE WILSON CONSUMER PRODUCTS LTD Presentation: Gel capsule, 10. Active Ingredients: Doxylamine succinate 25mg. Approved Indications: For the temporary relief of sleeplessness. Contraindications: Hypersensitivity to any ingredient. Precautions: Not recommended for children under 12 years. Dozile should be avoided during pregnancy or lactation. Do not use if packaging is torn or shows signs of tampering. Avoid alcohol. If tired, drowsy, dizzy or light-headed, do not drive or operate machinery. Do not use for more than 7-10 consecutive days. Adverse Effects: Most common side effects are dizziness, clumsiness, over-excitement. These are mostly mild and short-lived. Less common side effects are nausea, vomiting, diarrhoea, stomach problems, headache, dry mouth, difficulty passing urine, blurred vision, thick mucus from lungs, palpitations. Directions: Swallow 1 capsule whole with a glass of water 30 minutes before bedtime. Price Band: Under $10 Subsidy Conditions: Not subsidised Medicine Classification: Pharmacist Only »» Smoking Cessation HABITROL GUM GLAXOSMITHKLINE CONSUMER HEALTHCARE Presentation: Nicotine Chewing Gum: 2 mg and 4 mg. Fruit, Classic or Mint flavour. 96 pack (retail) and 384 pack (Dispensary). Active Ingredients: Nicotine. Approved Indications: Relief of nicotine withdrawal symptoms, as an aid for smoking cessation, smoking reduction or temporary abstinence from smoking. Contraindications: Non-smokers or occasional smokers, children under 12 years or known hypersensitivity to any ingredient in the formulation. Precautions: Medical advice before use in patients with a recent heart attack or stroke, uncontrolled hypertension, unstable or worsening angina or severe arrhythmia. A HCPs advice is needed if the patient has severe hypertension, stable angina, suffered a stroke, heart disease, heart failure, hyperthyroidism or pheochromocytoma, moderate to severe liver or kidney impairment, active peptic ulcer, diabetes, mouth/throat inflammation, dentures, under 18 years, inability to tolerate fructose, pregnant or breastfeeding. Discontinue if symptoms of nicotine overdose appear. Keep out of reach of children. Adverse Effects: Dizziness, headaches, insomnia, slight mouth/throat irritation, increased salivation, hiccupping, minor indigestion or heartburn, nausea, flatulence, gastritis, jaw muscle ache or a sore mouth or throat. Refer to datasheet for less common side effects. Directions: Those smoking more than 20 cigarettes/day, as well as smokers who failed to quit using 2mg gum, should use 4 mg strength. Otherwise, the 2 mg strength should be used. Only 2mg strength can be used in combination with patch. Refer to pack leaflet for more information. Price Band: $20 - $30 (Retail price varies with pack size). Available on Pharmaceutical Schedule Subsidy Conditions: Dispensing pack available with provision of Quitline card Medicine Classification: General Sale HABITROL LOZENGE GLAXOSMITHKLINE CONSUMER HEALTHCARE Presentation: Lozenge 1 mg and 2 mg. Mint flavour. 36 (retail) and 216 (dispensing) packs. Active Ingredients: Nicotine. Approved Indications: Relief of nicotine withdrawal symptoms, as an aid for smoking cessation, smoking reduction or temporarily abstinence from smoking. Contraindications: Non-smokers or occasional smokers, children under 12 years or known hypersensitivity to any ingredient in the formulation. Precautions: Medical advice before use in patients with a recent heart attack or stroke, uncontrolled hypertension, unstable or worsening angina or severe arrhythmia. A HCPs advice is needed if the patient has severe hypertension, stable angina, suffered a stroke, heart disease, heart failure, hyperthyroidism or pheochromocytoma, moderate to severe liver or kidney impairment, active peptic ulcer, diabetes, mouth/throat inflammation, under 18 years, pregnant or breastfeeding, phenylketonuria. Discontinue if symptoms of nicotine overdose appear. Keep out of reach of children. Adverse Effects: Dizziness, headaches, insomnia, slight mouth/throat irritation, increased salivation, hiccupping, minor indigestion or heartburn, nausea, flatulence, gastritis and dryness of the mouth. Refer to datasheet for less common side effects. Directions: Those smoking more than 20 cigarettes/day, as well as smokers who failed to quit using 1mg lozenge, should use 2 mg strength. Otherwise, the 1 mg strength should be used. Only 1mg strength can be used in combination with patch. Refer to pack leaflet for more information. Price Band: $20 - $25 (Retail price varies). Available on Pharmaceutical Schedule Subsidy Conditions: Dispensing pack available with provision of Quitline card Medicine Classification: General Sale Page 260 HEALTHCARE HANDBOOK 2017-2018 OTC Products

HABITROL PATCH GLAXOSMITHKLINE CONSUMER HEALTHCARE Presentation: Patch: Step 1 (21mg/24hrs), Step 2 (14mg/24hrs) and Step 3 (7mg/24hrs). Pack of 7 (retail) or 28 (dispensary). Active Ingredients: Nicotine. Approved Indications: Treatment of nicotine dependence, to aid smoking cessation. Combination therapy with Habitrol 2 mg gum or Habitrol 1 mg lozenge is permitted. Contraindications: Non-smokers or occasional smokers, under 12 years, generalised dermatological disorders such as psoriasis or chronic dermatitis that may complicate patch therapy or known hypersensitivity to any ingredient in the formulation. Precautions: Seek medical advice before use in people with a history of recent heart attack or stroke, uncontrolled hypertension, unstable or worsening angina or severe arrhythmias. Seek a doctor or pharmacists advice before using with other conditions of concern (see leaflet or datasheet). Discontinue treatment if symptoms of nicotine overdose appear. Keep out of reach of children. Adverse Effects: Application site reactions, agitation, anxiety, nervousness, insomnia, abnormal dreams, headache, dizziness, motor dysfunction, cough, nausea, abdominal pain, dyspepsia, myalgia and arthritis. Refer to datasheet for more information. Directions: Apply 1 patch daily. Those smoking more than 20 cigarettes/day should start with Step 1 Patch. Those smoking less than 20 cigarettes/day start with Habitrol Step 2. Refer to leaflet for further directions Medicine Classification: General Sale Price Band: $20 - $30 (Retail price varies with pack size). Available on Pharmaceutical Schedule Subsidy Conditions: Dispensing pack available with provision of Quitline card. NICORETTE 16HR INVISIPATCH PATCH JOHNSON & JOHNSON (NEW ZEALAND) LTD Presentation: Patch: Step 1 (25mg/16hr), Step 2 (15mg/16hr) and Step 3 (10mg/16hr). Packs of 7s. Active Ingredients: Nicotine. Indications: Smoking cessation aid. Smoking reduction. 2mg gum, 2mg Cooldrops lozenge, QuickMist and 15mg inhalator are approved for combination use with NICORETTE® patch. Contraindications: Generalised chronic dermatological disorders, such as psoriasis, chronic dermatitis or urticarial, hypersensitivity to nicotine, non-smokers, children, breast feeding. Precautions: Concomitant smoking, cardiovascular disease (including recent myocardial infarction), diabetes, hyperthyroidism, phaeochromocytoma, pregnancy, dermatological disorders. Adverse Effects: Headache, dizziness, gastrointestinal discomfort, nausea, vomiting erythema, itching of the skin. Directions: For adults 18+ who smoke more than 15 cigarettes per day, use one 25mg/16hr patch daily for the first 8 weeks followed by one 15mg/16hr patch daily for the next 2 weeks and 10mg/16hr patch daily for a further 2 weeks. For adults 18+ who smoke less than 15 cigarettes per day, use one 15mg/16hr patch daily for the first 8 weeks followed by one 10mg/16hr patch daily for the next 4 weeks Price Band: $25 - $35 and over Subsidy Conditions: Not subsidised Medicine Classification: General Sale NICORETTE COOLDROPS LOZENGE JOHNSON & JOHNSON (NEW ZEALAND) LTD Presentation: Lozenge (Icy Mint), 2 mg or 4 mg strength in packs of 80s. Active Ingredients: Nicotine. Indications: Smoking cessation aid. Temporary abstinence. Smoking reduction. 2mg is also approved for combination use with NICORETTE® Patch. Contraindications: Hypersensitivity to nicotine, non-smokers, children. Precautions: Concomitant smoking, peptic ulcer disease, cardiovascular disease (including recent myocardial infarction), diabetes, GI disease, hyperthyroidism, phaeochromocytoma, pregnancy or nursing mothers. Adverse Effects: Hiccups, nausea, headache, dizziness, heartburn, mouth irritation and indigestion, coughing, sore throat and chest palpitations. Directions: 2mg for adults 18+ who smoke 20 cigarettes or less per day. 4mg for adults 18+ who smoke more than 20 cigarettes per day. During weeks 1-12: use 1 lozenge when you have an urge to smoke or every 1-2 hours. After 12 weeks: Gradually reduce to 1-2 lozenges/day and then stop use. Do not use more than 15 lozenges per day. Price Band: $35 - $45 and over Subsidy Conditions: Not subsidised Medicine Classification: General Sale NICORETTE GUM JOHNSON & JOHNSON (NEW ZEALAND) LTD Presentation: Gum (Icy Mint), 2mg or 4mg in packs of 15s or 105s. Gum (Classic) 2mg or 4mg in packs of 105s. Active Ingredients: Nicotine. Indications: Smoking cessation aid. Temporary abstinence. Smoking reduction. 2mg is also approved for combination use with Nicorette Patch. Contraindications: Hypersensitivity to nicotine, non-smokers, children. Precautions: Concomitant smoking, peptic ulcer disease, cardiovascular disease (including recent myocardial infarction), diabetes, hyperthyroidism, phaeochromocytoma, pregnancy or nursing mothers. Adverse Effects: Occasionally, irritation of mouth and throat, hiccups, cough, indigestion, headache, nausea, vomiting. Directions: 2mg for adults 18+ who smoke less than 20 cigarettes per day. 4mg for adults 18+ who smoke more than 20 cigarettes per day. During weeks 1-12: Chew 1 pc when you have an urge to smoke or every 1-2 hours. After 12 weeks: Gradually reduce to 1-2 pcs a day and then stop use. Do not use more than 20pcs per day of the 2mg gum or 10 pcs per day of the 4mg gum. Price Band: $10 - $20 and over Subsidy Conditions: Not subsidised Medicine Classification: General Sale Page 261

  • Page 1 and 2:

    HEALTHCARE HANDBOOK incorporating t

  • Page 3 and 4:

    2017-2018 HEALTHCARE HANDBOOK PUBLI

  • Page 5 and 6:

    Index Common Disorders Acne--------

  • Page 7 and 8:

    Asthma and COPD CONTINUING OTC EDUC

  • Page 9 and 10:

    Head and scalp • Condition of hai

  • Page 11 and 12:

    HELP KIDS BE THEMSELVES AGAIN NEW L

  • Page 14 and 15:

    NUROFEN ZAVANCE* IS ABSORBED UP TO

  • Page 16 and 17:

    Acne Acne is a common skin problem

  • Page 18 and 19:

    Allergies An allergy occurs when th

  • Page 20 and 21:

    Asthma and COPD Asthma New Zealand

  • Page 22 and 23:

    Baby Feeding Breastfeeding is best

  • Page 24 and 25:

    Bites and Stings Bites and stings c

  • Page 26 and 27:

    Bruises, Scars, Spider Veins Bruise

  • Page 28 and 29:

    Childhood Diseases and Immunisation

  • Page 30 and 31:

    Childhood Diseases and Immunisation

  • Page 32 and 33:

    Childhood Diseases and Immunisation

  • Page 34 and 35:

    Childhood Diseases and Immunisation

  • Page 36 and 37:

    Childhood Pain and Baby Teething Pa

  • Page 38 and 39:

    Colds A cold is a contagious viral

  • Page 40 and 41:

    Cold Sores Cold sores are fluid-fil

  • Page 42 and 43:

    Constipation Constipation is the te

  • Page 44 and 45:

    Contraception & Sexual Wellbeing Co

  • Page 46 and 47:

    Contraception: Emergency Emergency

  • Page 48 and 49:

    Coughs: Dry Coughs are called dry o

  • Page 50 and 51:

    Coughs: Productive Coughs are consi

  • Page 52 and 53:

    Cuts, Abrasions and Blisters This t

  • Page 54 and 55:

    Cystitis [Bladder Infection] Cystit

  • Page 56 and 57:

    Dandruff Dandruff is a common condi

  • Page 58 and 59:

    Dermatitis/Eczema Dermatitis is a g

  • Page 60 and 61:

    Diabetes Diabetes is a condition in

  • Page 62 and 63:

    Diarrhoea and Vomiting Diarrhoea an

  • Page 64 and 65:

    Dry Skin Dry skin is skin that lack

  • Page 66 and 67:

    Ear Conditions Our ears allow us to

  • Page 68 and 69:

    Eye Conditions Almost two-thirds of

  • Page 70 and 71:

    Eye Conditions (continued) Type Sym

  • Page 72 and 73:

    Eyes: Contact Lenses Contact lenses

  • Page 74 and 75:

    Fever What is fever Fever is define

  • Page 76 and 77:

    Foot Care Common foot problems incl

  • Page 78 and 79:

    Fungal Infections: Superficial Supe

  • Page 80 and 81:

    Fungal Nail Infections (Onychomycos

  • Page 82 and 83:

    Gout Historically known as the “d

  • Page 84 and 85:

    Haemorrhoids Haemorrhoids (also cal

  • Page 86 and 87:

    Hair Loss Alopecia is the medical t

  • Page 88 and 89:

    Hay Fever Hay fever (also called in

  • Page 90 and 91:

    Hay Fever (continued) TREATMENT OPT

  • Page 92 and 93:

    Headache Headaches are common and c

  • Page 94 and 95:

    Head Lice Head lice (pediculosis ca

  • Page 96 and 97:

    Heart Health Cardiovascular (CV) di

  • Page 98 and 99:

    Indigestion, Heartburn and Gastriti

  • Page 100 and 101:

    Influenza Influenza (flu) is a comm

  • Page 102 and 103:

    Influenza (continued) TREATMENT OPT

  • Page 104 and 105:

    Iron Deficiency Iron is an essentia

  • Page 106 and 107:

    Irritable Bowel Syndrome Irritable

  • Page 108 and 109:

    Menopause Menopause - the “change

  • Page 110 and 111:

    Migraine Migraines are a type of se

  • Page 112 and 113:

    Muscular Aches, Pains and Tightness

  • Page 114 and 115:

    Nappy Rash Nappy rash is a red rash

  • Page 116 and 117:

    Oral Health Oral health disorders i

  • Page 118 and 119:

    Osteoarthritis Osteoarthritis is th

  • Page 120 and 121:

    Osteoporosis Osteoporosis (meaning

  • Page 122 and 123:

    Period Pain and Endometriosis Perio

  • Page 124 and 125:

    Poisonings Any substance that has t

  • Page 126 and 127:

    Pregnancy Tests and Supplements Hom

  • Page 128 and 129:

    Preventive Health There are certain

  • Page 130 and 131:

    Probiotics and Prebiotics Probiotic

  • Page 132 and 133:

    Psoriasis Psoriasis is a long-term

  • Page 134 and 135:

    Scabies Scabies is a very contagiou

  • Page 136 and 137:

    Shingles Shingles (herpes zoster) i

  • Page 138 and 139:

    Sinus and Nasal Problems Sinuses ar

  • Page 140 and 141:

    Sleep Problems and Snoring Sleep is

  • Page 142 and 143:

    Smoking Cessation Almost 5000 New Z

  • Page 144 and 145:

    Sore Throat Sore throats are very c

  • Page 146 and 147:

    Strains and Sprains Sprains and str

  • Page 148 and 149:

    Sun Care Sunburn Sunburn occurs fro

  • Page 150 and 151:

    Sun Care: Eye Protection Protecting

  • Page 152 and 153:

    Sweating: Excessive (Hyperhidrosis)

  • Page 154 and 155:

    Toothache Toothache is the term use

  • Page 156 and 157:

    Travel Health (including Vaccinatio

  • Page 158 and 159:

    Travel Sickness Travel, or motion,

  • Page 160 and 161:

    Urinary Incontinence Urinary incont

  • Page 162 and 163:

    Urticaria (Hives) Urticaria refers

  • Page 164 and 165:

    Vaginal Health The vagina is a clos

  • Page 166 and 167:

    Varicose Veins and Support Stocking

  • Page 168 and 169:

    Vitamins and Dietary Supplements Vi

  • Page 170 and 171:

    Warts Warts are benign (non-cancero

  • Page 172 and 173:

    Weight Loss Obesity has reached epi

  • Page 174 and 175:

    Worms Pinworms (Enterobius vermicul

  • Page 176 and 177:

    Wound Care Our skin acts as a barri

  • Page 178 and 179:

    Wound Care (continued) Wound type M

  • Page 180 and 181:

    Glossary WHAT DOES THAT WORD MEAN?

  • Page 182 and 183:

    Chapter References (continued) Diar

  • Page 184 and 185:

    Chapter References (continued) Gord

  • Page 186 and 187:

    Significant learning opportunity: W

  • Page 188 and 189:

    PharmacyToday A part of your everyd

  • Page 190 and 191:

    OTC Medicines: Interactions When se

  • Page 192 and 193:

    OTC Medicines: Interactions OTC Med

  • Page 194 and 195:

    OTC Medicines: Interactions OTC Med

  • Page 196 and 197:

    OTC Medicines: Interactions OTC Med

  • Page 198 and 199:

    OTC Medicines: Precautions OTC Medi

  • Page 200 and 201:

    OTC Medicines: Precautions OTC Medi

  • Page 202 and 203:

    OTC Medicines: Adverse Effects OTC

  • Page 204 and 205:

    Herbal Supplements: Interactions He

  • Page 206 and 207:

    Herbal Supplements: Interactions He

  • Page 208 and 209:

    Herbal Supplements: Interactions He

  • Page 210 and 211:

    Herbal Supplements: Interactions He

  • Page 212 and 213:

    Drugs in Sport Treating Athletes Me

  • Page 214 and 215:

    Drugs in Aviation AVIATION - PRECAU

  • Page 216 and 217:

    Drugs in Pregnancy Drug use in preg

  • Page 218 and 219: NZ Support Groups ADHD Association
  • Page 220 and 221: NZ Support Groups New Zealand AIDS
  • Page 222 and 223: HEAT or INFLAMMATION Unlike heat ru
  • Page 224 and 225: OTC Products Over-the-counter produ
  • Page 226 and 227: OTC Products Index Foot Care - Fung
  • Page 228 and 229: »» Acne CRYSTADERM CREAM AFT PHAR
  • Page 230 and 231: »» Childhood Pain and Baby Teethi
  • Page 232 and 233: »» Colds BONNINGTON’S IRISH MOS
  • Page 234 and 235: CODRAL RELIEF MAX STRENGTH COLD & F
  • Page 236 and 237: OTRIVIN JUNIOR GLAXOSMITHKLINE CONS
  • Page 238 and 239: DULCOLAX SANOFI CONSUMER HEALTHCARE
  • Page 240 and 241: BENADRYL MUCUS RELIEF DOUBLE ACTION
  • Page 242 and 243: »» Dandruff COCO-SCALP AFT PHARMA
  • Page 244 and 245: EAR CLEAR WILSON CONSUMER PRODUCTS
  • Page 246 and 247: »» Foot Care - Fungal Infections
  • Page 248 and 249: TELFAST ORAL LIQUID SANOFI CONSUMER
  • Page 250 and 251: NUROFEN ZAVANCE RECKITT BENCKISER (
  • Page 252 and 253: MOOV HEAD LICE SOLUTION DOUGLAS PHA
  • Page 254 and 255: GAVISCON DUAL ACTION LIQUID RECKITT
  • Page 256 and 257: CODRAL COLD & FLU + COUGH JOHNSON &
  • Page 258 and 259: »» Irritable Bowel Syndrome GASTR
  • Page 260 and 261: VOLTAREN EMULGEL GLAXOSMITHKLINE CO
  • Page 262 and 263: TURMERIC EXTRA STRENGTH GOOD HEALTH
  • Page 264 and 265: PREGNOSIS EARLY PREGNANCY TEST DIP
  • Page 266 and 267: »» Sexual Wellbeing - Contracepti
  • Page 270 and 271: NICORETTE INHALATOR JOHNSON & JOHNS
  • Page 272 and 273: STREPSILS PLUS LOZENGES RECKITT BEN
  • Page 274 and 275: TRAVACALM TRAVEL BAND WILSON CONSUM
  • Page 276 and 277: CRYSTADERM CREAM AFT PHARMACEUTICAL
  • Page 278 and 279: An ENHANCED ELearning Experience As
  • Page 280 and 281: Product Index ANIME LUBRICANT 50ML-
  • Page 282 and 283: Manufacturer’s Index AFT Pharmace
  • Page 284: Topiramate Actavis Topiramate 25mg,
Clinicians’ Perspec.ves on Biosimilars
Get Out! GAY Magazine – Issue 345 – December 6, 2017
Get Out! GAY Magazine – Issue 344 – November 29, 2017
Physicians to Keep Top of Mind in 2017
Safe and Secure Handling of Medicines Within ... - GGC Prescribing
pharmacists in secure environments - Royal Pharmaceutical Society
- do they work? - Bpac.org.nz
here - Alliance for Safe Biologic Medicines
Get Out! GAY Magazine – Issue 324 – July 12, 2017
healthpgm_pres_nov2013_en
Taking a Stand: Get Tested - New York State Department of Health
Dill Juice Market size and Key Trends in terms of volume and value 2016-2026
DIA Presentation on Biosimilar Naming - Alliance for Safe Biologic ...
Survey-analysis-2017
GPhA-biosimilars-handbook
EU Initiative on Combating Counterfeit Medicines
The Stockholm Network Experts' Series The UK Pharmaceutical ...